BioValley News

21.01.2014

Basel based 4-Antibody sold to Agenus

Boston based Agenus announced to acquire all of the outstanding stocks of 4-Antibody. The initial payment of $10...[more]


21.01.2014

Roche is back in the field of RNA based therapeutics

Three years ago, Roche stepped out of RNA based therapeutics research, a field that has once been believed to be a game...[more]


11.12.2013

University of Pennsylvania and Novartis present groundbreaking results at ASH

A few months ago Novartis announced to invest 20 million dollars to license a gene therapy technology from the...[more]


11.12.2013

Roche and Molecular Partners close a 1 billion dollar deal

Roche, which has with Kadcyla one of the most advanced anti-body drug conjugates on the market, has entered a...[more]


International News

18.12.2014

Fine particulate air pollution linked with increased autism risk

(Harvard School of Public Health) Women exposed to high levels of fine particulate matter specifically during pregnancy -- particularly during the third trimester -- may face up to twice the risk of having a child with autism than mothers living in areas with low particulate matter, according to a study from Harvard School of Public Health. The greater the exposure, the greater the risk, researchers found. It was the first US-wide study exploring the link between airborne particulate matter and autism.


18.12.2014

High-dose flu vaccine appears better for frail older adults in long-term care

(Infectious Diseases Society of America) For frail older adults living in long-term care facilities, the high-dose influenza vaccine appears to be a better option than the regular shot, producing a stronger immune response than the standard vaccine, according to a study published in The Journal of Infectious Diseases and now available online. High-dose vaccine may play a key role, along with improving vaccination rates among health care workers and other strategies, in preventing flu in this vulnerable and growing population.


18.12.2014

High-dose flu vaccine superior for frail elderly living in long-term care facilities

(University of Pittsburgh Schools of the Health Sciences) The high-dose flu vaccine is significantly better than the regular flu shot at boosting the immune response to the flu virus in frail, older residents of long-term care facilities, according to the results of a University of Pittsburgh School of Medicine study. It is the first evaluation of the vaccine in long-term care residents, which is the population most vulnerable to flu-related death.


About BioValley Basel

BioValley Basel is a Non-Profit organisation. It is the Swiss pillar of the trinational BioValley Initiative.

BioValley Basel aims at:

  • FOSTER a networking and integration platform amongst the Life Sciences Community in the Basel Region
  • ENABLE and FACILITATE an open network, beyond political and geographical boundaries
  • MODERATE and SUPPORT networking activities for the regional Life Sciences Community

Read more

Useful Links / Infos

Please find many interesting information and links in this section:

Job Market

Office Spaces

Databases

  • Company Database
  • Enterprise Europe Network Database

Living in Basel

  • Restaurants & Bars
  • Hotel Guide
  • Housing Market

Partner